View in EDS

Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum.

Saved in:
Bibliographic Details
Title: Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum.
Authors: Persson CU; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden., von Stedingk K; Department of Pediatrics, Clinical Sciences, Lund University, Lund, Sweden., Bexell D; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden., Merselius M; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden., Braekeveldt N; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden., Gisselsson D; Department of Clinical Genetics, Lund University, Department of Pathology, University and Regional Laboratories, Lund, Sweden., Arsenian-Henriksson M; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, SE-171 77, Stockholm, Sweden., Påhlman S; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden., Wigerup C; Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden. caroline.wigerup@med.lu.se.
Source: Scientific reports [Sci Rep] 2017 Aug 31; Vol. 7 (1), pp. 10274. Date of Electronic Publication: 2017 Aug 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-2322
DOI:10.1038/s41598-017-09662-8